Discussion of HIV-1-mediated aberrant immune activation of NK cells, and impaired host immune response as an indicator of disease progression.
No takes yet. Share an insight, caveat, or question.
Lugli et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: